Abstract
Physicochemical properties of the nanoparticles are associated to their in-vivo behavior including pharmacokinetic, bio-distribution, efficacy, and toxicity profiles. It is imperative to gain a comprehensive understanding of the nanoparticle properties through their characterization. Characterization of nanomaterials depends upon their unique physical and chemical properties with different level of complexity at molecular levels. Distinct properties of nanoparticles often hinder when standard methods of characterization of particles are used, which compromise the reliability and reproducibility of the outcome. Nano-therapeutics characterization depends on various aspects, including the encapsulated drug, delivery vehicles, disease, route of administration, dosing amount and its application. The precise control over nanoparticle properties need robust and advanced characterization techniques. Generally, characterization of nanoparticles is based on the composition, size- distribution, morphology, surface charge, purity and stability, using sophisticated techniques such as dynamic light scattering (DLS), scanning electron microscopy (SEM), transmission electron microscopy (TEM), atomic force microscopy (AFM) etc. Mean particle size, morphology and surface charge of nanoparticles affect their physical stability, re-dispersibility and in-vivo biodistribution. This chapter summarizes the basic principles, associated challenges and practical concerns in standard and promising physicochemical techniques used for characterization of nanoparticles.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Joshi, M.; Bhattacharyya, A.; Ali, S. W. Characterization techniques for nanotechnology applications in textiles. 2008.
Boegh M, Foged C, Müllertz A, Nielsen HM. Mucosal drug delivery: barriers, in vitro models and formulation strategies. Journal of Drug Delivery Science and Technology. 2013;23(4):383–91.
Ong KJ, MacCormack TJ, Clark RJ, Ede JD, Ortega VA, Felix LC, Dang MK, Ma G, Fenniri H, Veinot JG, Goss GG. Widespread nanoparticle-assay interference: implications for nanotoxicity testing. PLoS One. 2014;9(3):e90650. https://doi.org/10.1371/journal.pone.0090650.
Lin P-C, Lin S, Wang PC, Sridhar R. Techniques for physicochemical characterization of nanomaterials. Biotechnol Adv. 2014;32(4):711–26.
Laffleur F, Bernkop-Schnürch A. Strategies for improving mucosal drug delivery. Nanomedicine. 2013;8(12):2061–75.
Lu, Y.; Park, K. Appendix f: chapter ii. 5.16—drug delivery systems: H, Mucosal drug delivery.
Hoshyar N, Gray S, Han H, Bao G. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine. 2016;11(6):673–92. https://doi.org/10.2217/nnm.16.5.
Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res. 1997;14(11):1568–73. https://doi.org/10.1023/a:1012126301290.
Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm. 2008;69(1):1–9.
Patri A, Dobrovolskaia M, Stern S, McNeil S, Amiji M. Preclinical characterization of engineered nanoparticles intended for cancer therapeutics. Nanotechnology for cancer therapy. 2007:105–38.
Norris DA, Puri N, Sinko PJ. The effect of physical barriers and properties on the oral absorption of particulates. Adv Drug Deliv Rev. 1998;34(2–3):135–54.
Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev. 2009;61(2):158–71. https://doi.org/10.1016/j.addr.2008.11.002.
Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci. 2006;90(2):296–303.
Toy R, Peiris PM, Ghaghada KB, Karathanasis E. Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine. 2014;9(1):121–34. https://doi.org/10.2217/nnm.13.191.
Yu MK, Park J, Jon S. Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics. 2012;2(1):3–44. https://doi.org/10.7150/thno.3463.
Xu R. Progress in nanoparticles characterization: sizing and zeta potential measurement. Particuology. 2008;6(2):112–5.
Clogston JD, Patri AK. Zeta potential measurement. In: Characterization of nanoparticles intended for drug delivery: Springer; 2011. p. 63–70.
Bhatia S. Nanoparticles types, classification, characterization, fabrication methods and drug delivery applications. In: Natural polymer drug delivery systems: Springer; 2016. p. 33–93.
Gabor F, Bogner E, Weissenboeck A, Wirth M. The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. Adv Drug Deliv Rev. 2004;56(4):459–80. https://doi.org/10.1016/j.addr.2003.10.015.
Menzel C, Bernkop-Schnurch A. Enzyme decorated drug carriers: targeted swords to cleave and overcome the mucus barrier. Adv Drug Deliv Rev. 2018;124:164–74. https://doi.org/10.1016/j.addr.2017.10.004.
Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70(1–2):1–20.
Cho EJ, Holback H, Liu KC, Abouelmagd SA, Park J, Yeo Y. Nanoparticle characterization: state of the art, challenges, and emerging technologies. Mol Pharm. 2013;10(6):2093–110.
Berne BJ, Pecora R. Dynamic light scattering: with applications to chemistry, biology, and physics: Courier Corporation; 2000.
Griffiths, P. C.; Cattoz, B.; Ibrahim, M. S.; Anuonye, J. C. Probing the interaction of nanoparticles with mucin for drug delivery applications using dynamic light scattering. European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 2015, 97 (Pt A), 218–222, doi: https://doi.org/10.1016/j.ejpb.2015.05.004.
Mourdikoudis S, Pallares RM, Thanh NTK. Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties. Nanoscale. 2018;10(27):12871–934. https://doi.org/10.1039/c8nr02278j.
Singh AK. Engineered nanoparticles: structure, properties and mechanisms of toxicity: Academic; 2015.
Luo Z. A practical guide to transmission Electron microscopy, volume II: advanced microscopy: Momentum Press; 2015.
Nagashima, K.; Zheng, J.; Parmiter, D.; Patri, A. K. Biological tissue and cell culture specimen preparation for TEM nanoparticle characterization. In Characterization of Nanoparticles Intended for Drug Delivery; Springer: 2011; pp 83–91.
Scalf J, West P, Part I. Introduction to nanoparticle characterization with AFM. Pacific Nanotechnology: Santa Clara (see www. nanoparticles. org/pdf/Scalf-West. pdf; 2006.
Cetin M, Atila A, Kadioglu Y. Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium. AAPS PharmSciTech. 2010;11(3):1250–6.
Sapsford KE, Tyner KM, Dair BJ, Deschamps JR, Medintz IL. Analyzing nanomaterial bioconjugates: a review of current and emerging purification and characterization techniques. Anal Chem. 2011;83(12):4453–88.
Ghosh Chaudhuri R, Paria S. Core/shell nanoparticles: classes, properties, synthesis mechanisms, characterization, and applications. Chem Rev. 2011;112(4):2373–433.
Ngo VKT, Nguyen HPU, Huynh TP, Tran NNP, Lam QV, Huynh TD. Preparation of gold nanoparticles by microwave heating and application of spectroscopy to study conjugate of gold nanoparticles with antibody E. coli O157: H7. Adv Nat Sci Nanosci Nanotechnol. 2015;6(3):035015.
Naderi M. Chapter Fourteen - Surface Area: Brunauer–Emmett–Teller (BET). In: Progress in Filtration and Separation: Academic; 2015. p. 585–608.
Ramalinga U, Clogston JD, Patri AK, Simpson JT. Characterization of nanoparticles by matrix assisted laser desorption ionization time-of-flight mass spectrometry. In: Characterization of nanoparticles intended for drug delivery: Springer; 2011. p. 53–61.
Sharma A, Vaghasiya K, Gupta P, Gupta UD, Verma RK. Reclaiming hijacked phagosomes: hybrid nano-in-micro encapsulated MIAP peptide ensures host directed therapy by specifically augmenting phagosome-maturation and apoptosis in TB infected macrophage cells. Int J Pharm. 2018;536(1):50–62.
Wang W, Zhang H, Kuzmenko I, Mallapragada S, Vaknin D. Assembling bare au nanoparticles at positively charged templates. Sci Rep. 2016;6:26462.
Alex AT, Joseph A, Shavi G, Rao JV, Udupa N. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery. Drug Deliv. 2016;23(7):2144–53.
Rolim T1, Cancino J, Zucolotto V. A nanostructured genosensor for the early diagnosis of systemic arterial hypertension. Biomed Microdevices. 2015 Feb;17(1):3.
Rahman M, Laurent S, Tawil N, Yahia LH, Mahmoudi M. Analytical methods for corona evaluations. In: Protein-Nanoparticle Interactions: Springer; 2013. p. 65–82.
Agnihotri S, Mukherji S, Mukherji S. Size-controlled silver nanoparticles synthesized over the range 5–100 nm using the same protocol and their antibacterial efficacy. RSC Adv. 2014;4(8):3974–83.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Vaghasiya, K., Sharma, A., Ray, E., Adlakha, S., Verma, R.K. (2020). Methods to Characterize Nanoparticles for Mucosal Drug Delivery. In: Muttil, P., Kunda, N. (eds) Mucosal Delivery of Drugs and Biologics in Nanoparticles. AAPS Advances in the Pharmaceutical Sciences Series, vol 41. Springer, Cham. https://doi.org/10.1007/978-3-030-35910-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-35910-2_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-35909-6
Online ISBN: 978-3-030-35910-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)